NCT01064986

Brief Summary

Corticosteroids are substances produced by the adrenal gland to help the body fight against infection or injury. Hydrocortisone is a man-made form of this substance. Endotoxin is a man-made substance, which causes the body to "mimic" sickness(fever,chills,and achiness)for a few hours. This study is designed to give hydrocortisone before and after Endotoxin to determine if this medication can prevent or relieve any of the symptoms caused by the Endotoxin.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
12

participants targeted

Target at below P25 for phase_1

Timeline
Completed

Started Feb 2010

Typical duration for phase_1

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

February 1, 2010

Completed
4 days until next milestone

First Submitted

Initial submission to the registry

February 5, 2010

Completed
4 days until next milestone

First Posted

Study publicly available on registry

February 9, 2010

Completed
2.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2012

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2012

Completed
Last Updated

May 22, 2014

Status Verified

May 1, 2014

Enrollment Period

2.8 years

First QC Date

February 5, 2010

Last Update Submit

May 20, 2014

Conditions

Keywords

Immune System

Outcome Measures

Primary Outcomes (1)

  • Physiological, Hematological, Immunological Responses

    0.5-24 hrs post Endotoxin administration

Study Arms (2)

A

PLACEBO COMPARATOR

IV Endotoxin plus saline vehicle (placebo)

Biological: Endotoxin, Lipopolysaccharide, LPSBiological: Placebo

B

ACTIVE COMPARATOR

IV Endotoxin plus IV hydrocortisone

Biological: Endotoxin, Lipopolysaccharide, LPS /EpinephrineBiological: Hydrocortisone

Interventions

Clinical Center Reference Endotoxin, lot 2, sterile saline, 1 ng/kg, bolus IV administration (\~5 minutes)

Also known as: Sodium Chloride Solution
A

Clinical Center Reference Endotoxin, lot 2, sterile saline, 1 ng/kg, continuous IV administration (Hydrocortisone 3mcg/kg/min)

Also known as: Solu-Cortef
B
PlaceboBIOLOGICAL

Saline vehicle (placebo)

A
HydrocortisoneBIOLOGICAL

Hydrocortisone

B

Eligibility Criteria

Age18 Years - 40 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • General good health as demonstrated by medical history, physical\& laboratory tests
  • Age between 18 and 40 years
  • Written informed consent prior to the performance of any study related procedures

You may not qualify if:

  • History of cancer, rheumatoid arthritis, or immunological, renal, hepatic, endocrine, neurologic, heart disease or hypertension
  • Any medication taken in past 48 hrs (except birth control)
  • Recent history of alcohol or drug abuse
  • Unable to provide written informed consent
  • Exposure to any experimental agent or procedure within 30 days of study
  • Pregnant or breast-feeding

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Rutgers-RWJMS

New Brunswick, New Jersey, 08901, United States

Location

MeSH Terms

Conditions

Infections

Interventions

EndotoxinsLipopolysaccharidesSodium ChlorideEpinephrinehydrocortisone hemisuccinateHydrocortisone

Intervention Hierarchy (Ancestors)

Bacterial ToxinsToxins, BiologicalBiological FactorsGlycoconjugatesCarbohydratesPolysaccharides, BacterialPolysaccharidesLipidsAntigens, BacterialAntigensChloridesHydrochloric AcidChlorine CompoundsInorganic ChemicalsSodium CompoundsEthanolaminesAmino AlcoholsAlcoholsOrganic ChemicalsAminesBiogenic MonoaminesBiogenic AminesCatecholaminesCatecholsPhenolsBenzene DerivativesHydrocarbons, AromaticHydrocarbons, CyclicHydrocarbonsPregnenedionesPregnenesPregnanesSteroidsFused-Ring CompoundsPolycyclic Compounds11-HydroxycorticosteroidsHydroxycorticosteroidsAdrenal Cortex HormonesHormonesHormones, Hormone Substitutes, and Hormone Antagonists17-Hydroxycorticosteroids

Study Officials

  • Siobhan Corbett, MD

    Rutgers-RWJMS

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
phase 1
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, INVESTIGATOR
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

February 5, 2010

First Posted

February 9, 2010

Study Start

February 1, 2010

Primary Completion

December 1, 2012

Study Completion

December 1, 2012

Last Updated

May 22, 2014

Record last verified: 2014-05

Locations